Janssen Pharmaceuticals, Inc.

549300KW7Q8FTDG2UO48

The entity

Status: Active
LEI status: Issued and current
Category: Company
Legal form: Business Corporation (3JTE)
Jurisdiction: US-PA
Entity created: December 18, 1978

Address

Country: United States
Legal address: C/O CT Corporation System, 600 North Second Street, Suite 40117101 HarrisburgUnited States (US-PA)
Head office: 1125 TRENTON-HARBOURTON RD08560-1504 TITUSVILLEUnited States (US-NJ)

Identifier

LEI: 549300KW7Q8FTDG2UO48
Registered: April 3, 2013 at 03:12 PM UTC
Last updated: July 15, 2026 at 01:23 PM UTC
Next renewal: July 19, 2027 at 12:27 PM UTC
Issuer: Bloomberg (5493001KJTIIGC8Y1R12)
Registered with: Pennsylvania Department of State (RA000632)
Identifier: 681308
Verified against: Pennsylvania Department of State (RA000632)
Verified as: 681308
Corroboration: Confirmed against a public register
GLEIF conformity: Meets the standard

Corporate structure

Owned by

Johnson & Johnson
Direct parent · Ultimate parentUnited States549300G0CFPGEF6X2043

Machine access

REST: https://lei.online/v1/entities/549300KW7Q8FTDG2UO48This record as JSON.
MCP: https://lei.online/mcpThe same data as an MCP tool.

Start a new search